Myrexis Competitors and Similar CompaniesClear all
Genocea Biosciences's competitors and similar companies include Oncopeptides.
 Genocea Biosciences Genocea Biosciences is a biopharmaceutical company developing T cell-directed vaccines and immunotherapies to treat infectious diseases and cancer. | ||
Founding Date | Founding Date 2006 | Founding Date 2000 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ | Locations Stockholm, SE HQ Stockholm, SE Los Altos, US Mountain View, US Waltham, US |
Employees | Employees 593% decrease | Employees 80 |
Valuation ($) | Valuation ($) 5.7 k | Valuation ($) 42.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $1.6m (FY, 2021) | Revenue (est.) kr71.1m (FY, 2025) |
Net income | Net income ($33.2m) (FY, 2021) | Net income (kr249.6m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Oncopeptides
HQ
Stockholm, SE
Employees
80
Oncopeptides is a clinical development pharmaceutical company.
View company